Results 121 to 130 of about 40,271 (232)
, 2001 RATIONALE: Evaluation of relationships between serum antipsychotic drug concentrations and clinical response may provide valuable information for rational dosage adjustments.
AVENOSO A +7 more
core +1 more source
Xanomeline and Trospium Chloride: Mechanism of Action, Clinical, and Translational Science
Clinical and Translational Science, Volume 19, Issue 9, September 2026.ABSTRACT Xanomeline‐trospium chloride (Cobenfy, formerly KarXT) is a first‐in‐class, oral central M1/M4 muscarinic receptor agonist approved for the treatment of schizophrenia in adults. Cobenfy represents a paradigm shift by avoiding direct dopamine D2 receptor blockade and thus significantly reduces the burden of metabolic, extrapyramidal, and ...
Samantha Avila, Ingrid L. Chen
wiley +1 more source
European Journal of Neuroscience, Volume 64, Issue 5, September 2026.We recorded fMRI data during the N‐back task from 38 individuals with schizophrenia and 128 healthy participants and used moderated mediation analysis to examine the interactions between childhood trauma, frontoparietal connectivity and working memory performance.
Aoife Warren +7 more
wiley +1 more source
Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia
, 2011 Mário Rodrigues Louzã1, Helio Elkis1, Sandra Ruschel2, Irismar Reis de Oliveira3, Rodrigo Affonseca Bressan4, Paulo Belmonte-de-Abreu5, Hamilton Grabowski6, José Carlos Appolinário71Universidade de Sã
Appolinário JC +7 more
core
The 2026 World Delirium Awareness Day Survey: Findings From Turkish Intensive Care Units
Nursing in Critical Care, Volume 31, Issue 5, September 2026.ABSTRACT Background Delirium is a common and serious complication in intensive care units (ICUs) and is associated with adverse patient outcomes. World Delirium Awareness Day (WDAD), observed annually on the second Wednesday of March, provides a platform for international point prevalence studies to evaluate delirium burden and care practices across ...
Öznur Erbay Dalli, Ebru Kiraner
wiley +1 more source
Risperidone treatment for ADHD in children and adolescents with bipolar disorder
, 2008 Joseph Biederman, Paul Hammerness, Robert Doyle, Gagan Joshi, Megan Aleardi, Eric MickPediatric Psychopharmacology Research Department, Massachusetts General Hospital, Boston, MA, USAObjective: Children and adolescents with bipolar disorder are also at ...
Paul Hammerness +5 more
core
Neurogastroenterology &Motility, Volume 38, Issue 9, September 2026.Continuous MCP dosing was associated with higher TD prevalence and earlier onset. Intermittent dosing, despite longer cumulative exposure, was associated with lower TD risk. These findings suggest that intermittent regimens may offer a safer MCP therapeutic strategy. ABSTRACT Background Tardive dyskinesia (TD) is an often irreversible movement disorder
Pierantonio Russo +2 more
wiley +1 more source
Risperidone mucoadhesive buccal tablets: formulation design, optimization and evaluation
, 2017 Burak Çelik Department of Pharmaceutical Technology, Faculty of Pharmacy, Bezmialem Vakif University, Fatih, Istanbul, Turkey Abstract: The aim of this study was to design and optimize risperidone (RIS) mucoadhesive buccal tablets for systemic ...
Çelik B
core
Combination therapy or monotherapy for the depressed type of schizoaffective disorder
Neuropsychiatric Disease and Treatment, 2009 Lubomira Izáková1, Ivan Andre1, Angelos Halaris21Psychiatric Clinic, Faculty of Medicine Comenius University and Faculty Hospital, Bratislava, Slovakia; 2Department of Psychiatry and Behavioral Neurosciences, Loyola University ...
Lubomira Izáková +2 more
doaj
Risperidone (depot) for schizophrenia.
, 2017 BACKGROUND: Risperidone is the first new generation antipsychotic drug made available in a long-acting injection formulation. OBJECTIVES: To examine the effects of depot risperidone for treatment of schizophrenia or related psychoses in comparison with ...
VA Furtado (7923032) +3 more
core